Trial Profile
A multiple-center, randomized, single-blind, digoxin-controlled, parallel-group comparison study in atrial fibrillation and/or atrial flutter with low cardiac function
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 03 Jun 2016
Price :
$35
*
At a glance
- Drugs Landiolol (Primary)
- Indications Atrial fibrillation; Atrial flutter
- Focus Adverse reactions; Therapeutic Use
- Sponsors Ono Pharmaceutical
- 03 Jun 2016 New trial record